<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Expected probability of a successful program deciding between two or three phase III trials for a normally distributed outcome — EPsProg23_normal • drugdevelopR</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Expected probability of a successful program deciding between two or three phase III trials for a normally distributed outcome — EPsProg23_normal"><meta name="description" content="The function EPsProg23_normal() calculates the expected probability of a successful program
with a normally distributed outcome. This function follows a special decision rule in order to determine
whether two or three phase III trials should be conducted. First, two phase III trials are performed. Depending
on their success, the decision for a third phase III trial is made:
If both trials are successful, no third phase III trial will be conducted.
If only one of the two trials is successful and the other trial has a treatment effect that points in the same direction,
a third phase III trial will be conducted with a sample size of N3 = N3(ymin), which depends on an assumed minimal clinical relevant effect (ymin).
The third trial then has to be significant at level alpha
If only one of the two trials is successful and the treatment effect of the other points in opposite direction or
if none of the two trials are successful, then no third trial is performed and the drug development development program is not successful.
In the utility function, this will lead to a utility of -9999.

"><meta property="og:description" content="The function EPsProg23_normal() calculates the expected probability of a successful program
with a normally distributed outcome. This function follows a special decision rule in order to determine
whether two or three phase III trials should be conducted. First, two phase III trials are performed. Depending
on their success, the decision for a third phase III trial is made:
If both trials are successful, no third phase III trial will be conducted.
If only one of the two trials is successful and the other trial has a treatment effect that points in the same direction,
a third phase III trial will be conducted with a sample size of N3 = N3(ymin), which depends on an assumed minimal clinical relevant effect (ymin).
The third trial then has to be significant at level alpha
If only one of the two trials is successful and the treatment effect of the other points in opposite direction or
if none of the two trials are successful, then no third trial is performed and the drug development development program is not successful.
In the utility function, this will lead to a utility of -9999.

"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">drugdevelopR</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">1.0.2</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/Introduction-to-drugdevelopR.html">Introduction to planning phase II and phase III trials with drugdevelopR</a></li>
    <li><a class="dropdown-item" href="../articles/Package_validation.html">Package validation</a></li>
    <li><hr class="dropdown-divider"></li>
    <li><a class="dropdown-item" href="../articles/index.html">More articles...</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/Sterniii3/drugdevelopR/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>Expected probability of a successful program deciding between two or three phase III trials for a normally distributed outcome</h1>
      <small class="dont-index">Source: <a href="https://github.com/Sterniii3/drugdevelopR/blob/HEAD/R/functions_multitrial_normal.R" class="external-link"><code>R/functions_multitrial_normal.R</code></a></small>
      <div class="d-none name"><code>EPsProg23_normal.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The function <code>EPsProg23_normal()</code> calculates the expected probability of a successful program
with a normally distributed outcome. This function follows a special decision rule in order to determine
whether two or three phase III trials should be conducted. First, two phase III trials are performed. Depending
on their success, the decision for a third phase III trial is made:</p><ul><li><p>If both trials are successful, no third phase III trial will be conducted.</p></li>
<li><p>If only one of the two trials is successful and the other trial has a treatment effect that points in the same direction,
a third phase III trial will be conducted with a sample size of N3 = N3(ymin), which depends on an assumed minimal clinical relevant effect (<code>ymin</code>).
The third trial then has to be significant at level <code>alpha</code></p></li>
<li><p>If only one of the two trials is successful and the treatment effect of the other points in opposite direction or
if none of the two trials are successful, then no third trial is performed and the drug development development program is not successful.
In the utility function, this will lead to a utility of -9999.</p></li>
</ul></div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">EPsProg23_normal</span><span class="op">(</span></span>
<span>  <span class="va">kappa</span>,</span>
<span>  <span class="va">n2</span>,</span>
<span>  <span class="va">alpha</span>,</span>
<span>  <span class="va">beta</span>,</span>
<span>  <span class="va">w</span>,</span>
<span>  <span class="va">Delta1</span>,</span>
<span>  <span class="va">Delta2</span>,</span>
<span>  <span class="va">in1</span>,</span>
<span>  <span class="va">in2</span>,</span>
<span>  <span class="va">a</span>,</span>
<span>  <span class="va">b</span>,</span>
<span>  <span class="va">case</span>,</span>
<span>  <span class="va">size</span>,</span>
<span>  <span class="va">ymin</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-kappa">kappa<a class="anchor" aria-label="anchor" href="#arg-kappa"></a></dt>
<dd><p>threshold value for the go/no-go decision rule</p></dd>


<dt id="arg-n-">n2<a class="anchor" aria-label="anchor" href="#arg-n-"></a></dt>
<dd><p>total sample size for phase II; must be an even number</p></dd>


<dt id="arg-alpha">alpha<a class="anchor" aria-label="anchor" href="#arg-alpha"></a></dt>
<dd><p>significance level</p></dd>


<dt id="arg-beta">beta<a class="anchor" aria-label="anchor" href="#arg-beta"></a></dt>
<dd><p>type II error rate; this means that 1 - <code>beta</code> is the power for calculating the sample size for phase III</p></dd>


<dt id="arg-w">w<a class="anchor" aria-label="anchor" href="#arg-w"></a></dt>
<dd><p>weight for the mixture prior distribution</p></dd>


<dt id="arg-delta-">Delta1<a class="anchor" aria-label="anchor" href="#arg-delta-"></a></dt>
<dd><p>assumed true treatment effect for the standardized difference in means</p></dd>


<dt id="arg-delta-">Delta2<a class="anchor" aria-label="anchor" href="#arg-delta-"></a></dt>
<dd><p>assumed true treatment effect for the standardized difference in means</p></dd>


<dt id="arg-in-">in1<a class="anchor" aria-label="anchor" href="#arg-in-"></a></dt>
<dd><p>amount of information for <code>Delta1</code> in terms of sample size</p></dd>


<dt id="arg-in-">in2<a class="anchor" aria-label="anchor" href="#arg-in-"></a></dt>
<dd><p>amount of information for <code>Delta2</code> in terms of sample size</p></dd>


<dt id="arg-a">a<a class="anchor" aria-label="anchor" href="#arg-a"></a></dt>
<dd><p>lower boundary for the truncation</p></dd>


<dt id="arg-b">b<a class="anchor" aria-label="anchor" href="#arg-b"></a></dt>
<dd><p>upper boundary for the truncation</p></dd>


<dt id="arg-case">case<a class="anchor" aria-label="anchor" href="#arg-case"></a></dt>
<dd><p>number of significant trials needed for approval; possible values are 2 and 3 for this function</p></dd>


<dt id="arg-size">size<a class="anchor" aria-label="anchor" href="#arg-size"></a></dt>
<dd><p>effect size category; possible values are <code>"small"</code>, <code>"medium"</code>, <code>"large"</code> and <code>"all"</code></p></dd>


<dt id="arg-ymin">ymin<a class="anchor" aria-label="anchor" href="#arg-ymin"></a></dt>
<dd><p>assumed minimal clinical relevant effect</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>The output of the function <code>EPsProg23_normal()</code> is the expected probability of a successful program.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu">EPsProg23_normal</span><span class="op">(</span>kappa <span class="op">=</span> <span class="fl">0.1</span>, n2 <span class="op">=</span> <span class="fl">50</span>, alpha <span class="op">=</span> <span class="fl">0.025</span>, beta <span class="op">=</span> <span class="fl">0.1</span>, w <span class="op">=</span> <span class="fl">0.3</span>,</span></span>
<span class="r-in"><span>                                 Delta1 <span class="op">=</span> <span class="fl">0.375</span>, Delta2 <span class="op">=</span> <span class="fl">0.625</span>, in1 <span class="op">=</span> <span class="fl">300</span>, in2 <span class="op">=</span> <span class="fl">600</span>, </span></span>
<span class="r-in"><span>                                 a <span class="op">=</span> <span class="fl">0.25</span>, b <span class="op">=</span> <span class="fl">0.75</span>, </span></span>
<span class="r-in"><span>                                 case <span class="op">=</span> <span class="fl">2</span>, size <span class="op">=</span> <span class="st">"small"</span>, ymin <span class="op">=</span> <span class="fl">0.5</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 0.5443622</span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Stella Erdmann, Johannes Cepicka, Marietta Kirchner, Meinhard Kieser, Lukas D. Sauer.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

    </footer></div>





  </body></html>

